The manufacturer of Tanzeum plans to stop making the drug after July 2018. If you have patients who are now taking this drug to treat their diabetes, please make sure to give them new prescriptions.
Below is a list of our preferred Glucagon-Like Peptide-1 Receptor Agonist (GLP-1) products for your patients with commercial group and individual plans, including those sold through Access Health CT, the state insurance exchange.
Please note, non-preferred GLP-1 products will require preauthorization for all of your ConnectiCare patients.
Preferred products |
Non-preferred products |
---|---|
Byetta |
Adlyxin |
Bydureon |
Trulicity |
Ozempic |
|
Victoza |
|